1 – 11 of 11
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis
(
- Contribution to journal › Article
- 2013
-
Mark
Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al Reply
(
- Contribution to journal › Letter
- 2012
-
Mark
Brief Report: Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
(
- Contribution to journal › Article
- 2011
-
Mark
Long-term patient survival in ANCA-associated vasculitis
(
- Contribution to journal › Article
- 2010
-
Mark
EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis
(
- Contribution to journal › Article
- 2009
-
Mark
Long-term survival of ANCA-associated vasculitis
(
- Contribution to journal › Published meeting abstract
-
Mark
Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial
(
- Contribution to journal › Published meeting abstract
-
Mark
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
(
- Contribution to journal › Article
- 2007
-
Mark
Development of comprehensive disease assessment in systemic vasculitis
(
- Contribution to journal › Article
- 2003
-
Mark
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
(
- Contribution to journal › Article